Evidence map›Paper›PMID 41080540›Full record

ArticleFrontiers in immunology2025

Bridging inflammation and proliferation: scRNA-seq analysis of chemotactic and growth factor signaling in mouse skin wound repair.

Lingzhang Meng, Hongmian Li, Jian Song, Wenxian Lin, Xiuli Mao, Xiamin Zhang, Mingyue Yang, Kezhao Wu, Liu Lu, Feiteng Liang and 3 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lingzhang Meng *Institute of Cardiovascular Sciences, Guangxi Academy of Medical Sciences & The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Hongmian Li *Department of Emergency, Guangxi Academy of Medical Sciences & The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Jian Song *Institute of Cardiovascular Sciences, Guangxi Academy of Medical Sciences & The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Wenxian LinInstitute of Cardiovascular Sciences, Guangxi Academy of Medical Sciences & The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Xiuli MaoInstitute of Cardiovascular Sciences, Guangxi Academy of Medical Sciences & The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Xiamin ZhangInstitute of Cardiovascular Sciences, Guangxi Academy of Medical Sciences & The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Mingyue YangDepartment of Pharmacology, Youjiang Medical University for Nationalities, Baise, China.
Kezhao WuInstitute of Cardiovascular Sciences, Guangxi Academy of Medical Sciences & The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.
Liu LuKey Laboratory of Medical Research Basic Guarantee for Immune-related Diseases Research of Guangxi (Cultivation), Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Feiteng LiangKey Laboratory of Medical Research Basic Guarantee for Immune-related Diseases Research of Guangxi (Cultivation), Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Feng LongDepartment of Infectious Diseases, The People's Hospital of Beihai, Beihai, China.
Yueyong LiDepartment of Oncology, Changsha Central Hospital, University of South China, Changsha, China.
Qiang TangKey Laboratory of Medical Research Basic Guarantee for Immune-related Diseases Research of Guangxi (Cultivation), Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The transition from inflammation to proliferation is a critical but poorly understood phase in wound healing. To elucidate the cellular and molecular dynamics of this pivotal stage, we performed single-cell RNA sequencing (scRNA-seq) on mouse skin biopsies 4 days after injury. Methods: By employing our newly developed R packages, OptiRes for optimized clustering and TidyGenePlot for annotation, we identified 21 distinct cell types. CellChat analysis was used to identify intercellular communication clusters. Findings on chemotactic signaling through CCR5, CCR1, and ACKR1 were validated in vivo, and the functional significance was confirmed by demonstrating that inhibition of CCR pathways reduced phagocyte infiltration. Results: Our analysis revealed a dynamic shift in cellular composition, characterized by an influx of neutrophils, classical monocytes, and M1 macrophages. This recruitment of phagocytes was driven by enhanced chemotactic signaling through CCR5, CCR1, and ACKR1. Furthermore, CellChat analysis identified four distinct intercellular communication clusters, highlighting the early activation of VEGF and EGF signaling pathways, which are essential for angiogenesis and re-epithelialization. Discussion: Together, these findings provide a high-resolution map of the cellular and molecular landscape during the transition from inflammation to proliferation, offering novel insights into the mechanisms that orchestrate tissue repair and identifying potential intervention manner to enhance wound healing.

Indexed as

ChemotaxisInflammationIntercellular Signaling Peptides and ProteinsSignal TransductionSkinWound HealingAnimalsCell ProliferationMiceMice, Inbred C57BLReceptors, CCR1RNA-SeqSingle-Cell AnalysisSingle-Cell Gene Expression AnalysisIntercellular Signaling Peptides and ProteinsReceptors, CCR1chemotactic signalingmouse skin modelscRNA-seqVEGF and EGF pathwayswound healing

Identifiers

PMID41080540
PMCPMC12507807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.